# US 2015/0104513 A1 · Coating film, and granules and tablets each utilizing same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104513 A1
- Document ID: US20150104513A1
- Status: Published application
- Kind: A1
- Application number: 14/561,987
- Filed: 2014-12-05
- Published: 2015-04-16
- Earliest claimed: 2009-10-09
- Assignees: Asahi Kasei Chemicals Corporation
- Applicants: Asahi Kasei Chemicals Corporation
- Inventors: Naoya YOSHIDA; Kazuhiro OBAE
- Web page: https://patentgrep.com/patent/US20150104513A1

## CPC

- A61K 9/2054: {Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose}
- A61K 9/1611: {Inorganic compounds}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61K 9/2009: {Inorganic compounds}
- A61K 9/2013: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/2027: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 9/5026: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 31/522: having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
- C09D 101/08: Cellulose derivatives
- C09D 129/04: Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
- C09D 133/08: Homopolymers or copolymers of acrylic acid esters
- C09D 133/10: Homopolymers or copolymers of methacrylic acid esters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C09D: COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR (cosmetics A61K; processes for applying liquids or other fluent materials to surfaces, in general, B05D; staining wood B27K5/02; glazes or vitreous enamels C03C; natural resins, French polish, drying-oils, driers, turpentine, per se, C09F; polishing compositions other than French polish, ski waxes C09G; adhesives or use of materials as adhesives C09J; materials for sealing or packing joints or covers C09K3/10; materials for stopping leaks C09K3/12; processes for the electrolytic or electrophoretic production of coatings C25D)

## Abstract

A coating film comprising ethyl cellulose as a component A and an (ethyl acrylate)-(methyl methacrylate) copolymer or a plasticized vinyl acetate polymer as a component B, and having a tensile elongation of 150% or more and a tensile strength of 9 N or more.

## Claims

### Claim 1

A coating film comprising
Component A: an ethyl, cellulose, Component B: an ethyl acrylate/methyl methacrylate-copolymer or a plasticized vinyl acetate polymer. Component C: a polyvinyl alcohol copolymer, Component D: a plasticizer, and Component E: an inorganic substance,
wherein a mass ratio of the Components A:B:C:D:E is 100:(100 to 300):(6 to 90):(6 to 90):(30 to 90),
and having a tensile elongation of 150% or more and a tensile strength of 9 N or more.

### Claim 2 (depends on 1)

The coating film according to claim 1, wherein Component D is triethyl citrate.

### Claim 3 (depends on 1)

The coating film according to claim 1, wherein Component E is titanium oxide.

### Claim 4

A granule comprising a drug-containing elementary granule having the periphery thereof coated with a coating film, and having a drug dissolution rate of 10% or less in 1 minute and 90% or more in 30 minutes,
wherein “1st fluid for dissolution test” described in Japanese Pharmacopoeia is used as a dissolution medium by paddle method with a rotation speed of paddle at 100 rpm,
and further having an agglomeration ratio of 10% or less,
wherein the coating film is a coating film comprising Component A: an ethyl cellulose, Component B: an ethyl acrylate/methyl methacrylate copolymer or a plasticized vinyl acetate polymer, Component C: a polyvinyl alcohol copolymer. Component D: a plasticizer, and Component E: an inorganic substance, wherein a mass ratio of Components A:B:C:D:E is 100:000 to 300):(6 to 90):(6 to 90):(30 to 90), and having a tensile elongation of 150% or more and a tensile strength of 9 N or more.

### Claim 5 (depends on 4)

The granule according to claim 4 wherein the granule coating film has only a single layer and a drug dissolution rate when a compression force of maximum 25 kN is applied to the granule is within +/−10% of a drug dissolution rate of the granule to which a compression force is not applied.

### Claim 6 (depends on 5)

The granule according to claim 5, wherein the elementary granule contains a spherical core particle containing 70% by mass or more of a microcrystalline cellulose.

### Claim 7 (depends on 6)

A tablet containing 0.55 to 90.0% by mass of the granule according to claim 6.

### Claim 8 (depends on 7)

The tablet according to claim 7, further containing trehalose, a microcrystalline cellulose, a disintegrant, and a lubricant.

### Claim 9 (depends on 8)

The tablet according to claim 8, wherein a mass ratio of granule:trehalose:microcrystalline cellulose:disintegrant:lubricant is 100:(30 to 6900):(12 to 3000):(0.1 to 1000):(0.1 to 1000).
